Direkt zum Inhalt
Merck

Neonatal infectious diseases: evaluation of neonatal sepsis.

Pediatric clinics of North America (2013-03-14)
Andres Camacho-Gonzalez, Paul W Spearman, Barbara J Stoll
ZUSAMMENFASSUNG

Neonatal sepsis remains a feared cause of morbidity and mortality in the neonatal period. Maternal, neonatal, and environmental factors are associated with risk of infection, and a combination of prevention strategies, judicious neonatal evaluation, and early initiation of therapy are required to prevent adverse outcomes. This article reviews recent trends in epidemiology and provides an update on risk factors, diagnostic methods, and management of neonatal sepsis.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Fluconazol, ≥98% (HPLC), powder
Supelco
Fluconazol, Pharmaceutical Secondary Standard; Certified Reference Material
Fluconazol, European Pharmacopoeia (EP) Reference Standard
Fluconazol für die Peakidentifizierung, European Pharmacopoeia (EP) Reference Standard